ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000255343.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.013638555	Resistant
ENSG00000255343.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.021065781	Sensitive